NASDAQ:NRXP Long Term Investor Alert: Investigation Over Possible Wrongdoing at NRx Pharmaceuticals, Inc.

An investigation on behalf of current long term investors in NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) shares over possible breaches of fiduciary duty by certain officers and directors was announced.

San Diego, CA — (SBWIRE) — 05/16/2022 — Certain directors of NRx Pharmaceuticals, Inc. are under investigation over possible breaches of fiduciary duties.

Investors who are current long term investors in NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The investigation by a law firm for current long term investors in NASDAQ: NRXP stocks follows a lawsuit filed against NRx Pharmaceuticals, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: NRXP stocks, concerns whether certain NRx Pharmaceuticals, Inc. directors are liable in connection with the allegations made in that lawsuit.

The plaintiff alleges that, the Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the ZYESAMI EUA Application contained insufficient data regarding the potential benefits and risks of ZYESAMI; (ii) accordingly, the FDA was unlikely to approve the ZYESAMI EUA Application in its present form; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Those who purchased shares of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.sbwire.com/press-releases/nasdaqnrxp-long-term-investor-alert-investigation-over-possible-wrongdoing-at-nrx-pharmaceuticals-inc-1357663.htm

Media Relations Contact

Christopher Clausen
Shareholders Foundation
Telephone: 1-858-779-1554
Email: Click to Email Christopher Clausen
Web: https://www.shareholdersfoundation.com/